Sertraline
- Product NDC
- 51655-830
- 11-digit product format
- 516550830
- Labeler code
- 51655
- Product ID
- 51655-830_410d1ab4-cd1f-2b24-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals, LLC
- Application
- ANDA077397
- Marketing category
- ANDA
- Marketing start
- 2016-11-11
- Marketing end
- 0000-00-00
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-830 | SERTRALINE TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 1 | Legacy NDC | 20161112_410d1ab4-cd1e-2b24-e054-00144ff88e88.zip |